Suscribirse

Nanosuspensions: Enhancing drug bioavailability through nanonization - 18/07/24

Nanosuspensions : améliorer la biodisponibilité des médicaments par la nanonisation

Doi : 10.1016/j.pharma.2024.06.003 
Rohit Chavhan
 Yash institute of pharmacy, Dharmapur, India 

En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Thursday 18 July 2024

Highlights

Nanosuspensions revolutionize drug delivery: nanosuspensions represent a cutting-edge dosage form with the potential to transform drug delivery by enhancing the bioavailability of poorly soluble medications.
Critical role of particle size reduction: nanonization techniques play a pivotal role in reducing particle size, thereby overcoming challenges associated with low solubility in both aqueous and organic environments.
Versatility in administration routes: nanosuspensions offer versatility in administration routes, spanning parenteral, peroral, ocular, and pulmonary pathways, making them suitable for various dosage forms.
Diverse preparation techniques: various preparation techniques such as high-pressure homogenization, media milling, and precipitation contribute to the expanding repertoire of nanosuspension formulation methods, each offering unique advantages and limitations.
Focus on targeted drug delivery: ongoing research aims to further nanosuspensions’ application in site-specific drug delivery, indicating their potential for tailored therapeutic strategies.
Importance of formulation and stabilization: careful formulation and stabilization using polymers and surfactants are essential to ensure the efficacy and safety of nanosuspensions.
Comprehensive overview: the article provides a comprehensive overview of nanosuspensions, covering their benefits, drawbacks, characterization, patents, marketed products, and intended uses, serving as a valuable resource for future research endeavors in pharmaceutical sciences.

El texto completo de este artículo está disponible en PDF.

Summary

Introduction

Nanosuspensions have emerged as a promising avenue in pharmaceutical innovation, particularly for enhancing the bioavailability of poorly soluble medications. This article explores the transformative potential of nanosuspensions, emphasizing the critical role of particle size reduction through nanonization techniques. With conventional approaches often falling short in addressing the bioavailability challenges of hydrophobic drugs, nanosuspensions offer multifaceted applications and distinctive advantages in drug delivery.

Methods

The study delves into various nanosuspension preparation techniques, including high-pressure homogenization, media milling, emulsification-solvent evaporation, precipitation, and supercritical fluid processes. Each method brings unique advantages and limitations, contributing to the expanding repertoire of nanosuspension formulation methods. The article emphasizes the necessity for meticulous planning, evaluation, and ongoing research across different drugs to optimize their use effectively.

Results

Nanosuspensions exhibit versatility in administration routes, spanning parenteral, peroral, ocular, and pulmonary pathways, making them applicable across diverse dosage forms. Current efforts are directed towards furthering their application in site-specific medication administration, indicating their potential in tailored therapeutic strategies. Nanosuspensions offer a promising solution for enhancing drug solubility and bioavailability, addressing the persistent challenge of poor solubility in pharmaceutical compounds.

Discussion

The significance of careful formulation and stabilization using polymers and surfactants is underscored, ensuring the efficacy and safety of nanosuspensions. By discussing the benefits, drawbacks, and nuances of each preparation technique, the article aims to simplify future research endeavors in the field of nanosuspensions. Additionally, a comprehensive overview of nanosuspensions, including their preparation methods, benefits, characterization, patents, marketed products, and intended uses, sheds light on this evolving domain in pharmaceutical sciences.

Conclusion

Nanosuspensions represent a promising approach for overcoming bioavailability challenges associated with poorly soluble medications. The article highlights their transformative potential in pharmaceutical innovation, emphasizing the importance of continued research and optimization to harness their benefits effectively. Nanosuspensions offer a viable solution for enhancing drug solubility and bioavailability, with implications for improving therapeutic outcomes in various medical conditions.

El texto completo de este artículo está disponible en PDF.

Keywords : Nanosuspension, Nanonization, Bioavailability enhancement, Formulation techniques, Drug solubility, Versatile drug delivery


Esquema


© 2024  Académie Nationale de Pharmacie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.